πŸ‡ΊπŸ‡Έ FDA
Patent

US 11135284

MERS-CoV vaccine

granted A61KA61K2039/53A61K39/12

Quick answer

US patent 11135284 (MERS-CoV vaccine) held by Inovio Pharmaceuticals, Inc. expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/53, A61K39/12, A61K39/215, A61P